# A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

> **NCT03438604** · PHASE1 · COMPLETED · sponsor: **Corium, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Donepezil TDS

## Key facts

- **NCT ID:** NCT03438604
- **Lead sponsor:** Corium, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-13
- **Primary completion:** 2018-06-19
- **Final completion:** 2018-06-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03438604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03438604, "A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03438604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
